| 摘要 |
The present invention is directed to pharmaceutical compositions containing active compounds, which inhibit the activity of the chemokines, MIP-lalpha and RANTES. It also is directed to methods of treating inflammatory and immunoregulatory disorders and diseases using these pharmaceutical compositions.
|
